Trial Profile
Add-on Therapy With Low Dose Fenfluramine in Lennox Gastaut Epilepsy
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 25 Sep 2023
Price :
$35
*
At a glance
- Drugs Fenfluramine (Primary)
- Indications Lennox-Gastaut syndrome
- Focus Therapeutic Use
- 21 Sep 2023 Planned End Date changed from 1 Dec 2021 to 1 Dec 2024.
- 26 Jan 2021 Planned End Date changed from 1 Dec 2020 to 1 Dec 2021.
- 27 Jul 2020 Planned End Date changed from 1 Dec 2019 to 1 Dec 2020.